Vergent Bioscience Stock

vergentbio.comHealthcare / BioTech & PharmaFounded: 2016

Vergent Bioscience is a biopharma research and development company that specializes in the identification and treatment of cancers and tumors. Vergent Bioscience partners with scientist and healthcare organizations with their minimally invasive, robotic assisted techniques to improve the visibility of a variety of tumors that at times, can be undetectable or difficult to find. Furthermore, Vergent Bioscience’s clinical technology can aid in removing tumor tissue fully.

Register To Buy and Sell Shares

For more details on financing and valuation for Vergent Bioscience, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Vergent Bioscience’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Vergent Bioscience.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Vergent Bioscience’s stock FAQs


Can you buy Vergent Bioscience’s stock?

Vergent Bioscience is not publicly traded on NYSE or NASDAQ in the U.S. To buy Vergent Bioscience’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Vergent Bioscience’s stock?

Yes, you can sell stock of a private company like Vergent Bioscience. Forge can help you sell your Vergent Bioscience stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is Vergent Bioscience’s stock price?

Vergent Bioscience is a privately held company and therefore does not have a public stock price. However, you may access Vergent Bioscience’s private market stock price with Forge Data.

What is Vergent Bioscience’s stock ticker symbol?

Vergent Bioscience does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Vergent Bioscience Secures $21.5 Million Series B Financing to Advance Clinical Development of Tumor-Targeted Fluorescent Imaging Agent VGT-309

Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, today announced the close of a $21.5 million Series B financing.
Updated on: Jun 24, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.